CLASSICAL HODGKIN LYMPHOMA RECURRENT

Clinical trials for CLASSICAL HODGKIN LYMPHOMA RECURRENT explained in plain language.

Never miss a new study

Get alerted when new CLASSICAL HODGKIN LYMPHOMA RECURRENT trials appear

Sign up with your email to follow new studies for CLASSICAL HODGKIN LYMPHOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New shot in the arm for tough lymphomas: simpler treatment tested

Disease control Ongoing

This study is testing a new, under-the-skin version of an immunotherapy drug (pembrolizumab) for adults whose Hodgkin lymphoma or a related B-cell lymphoma has come back or not responded to prior treatments. The main goals are to see how the drug behaves in the body when given th…

Matched conditions: CLASSICAL HODGKIN LYMPHOMA RECURRENT

Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

CLASSICAL HODGKIN LYMPHOMA RECURRENT

Get alerted when new CLASSICAL HODGKIN LYMPHOMA RECURRENT trials appear

New shot in the arm for tough lymphomas: simpler treatment tested